Pharma Focus Asia
KP - Sustainable Packaging Solutions

Merck to Invest US$118 million in New Gene Therapy Manufacturing Plant

Introduction:

Merck, with an investment of US$118 million (€100 million) plans to build a new gene therapy manufacturing capacity to double the size of the existing capacity. The new manufacturing site will be located in Carlsbad, California, USA.

Features:

This expansion is designed t0 produce large-scale commercial manufacturing of viral and gene therapy products.

The newly manufacturing facility with 140,000-square-foot will be utilised for the production of viral and gene therapies at the 1000-liter scale by using Mobius® single-use equipment.

This expansion enables gene therapies on a large scale and benefits the patients. Moreover, it will also add 11 suites, bringing the total to 27, which are used in various steps of manufacturing.

The new commercial facility which is likely to open next year will double the size of the existing facility.

Specifications:

NameMerck
TypeExpansion
BudgetUS$118 million
Latest Issue
Get instant
access to our latest e-book
Standard BioTools™MFA + MMA 2024Gibco Adherent Kidney Media PanelAsia Healthcare Week 2024Equinix accelerated medical research...CPHI Korea 2024CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?